MMP9 and triple-A syndrome: Noda et al. demonstrated that vildagliptin, another DPP-4 inhibitor, significantly diminished the formation of AAA and reduced expression of MMP-2, MMP-9, and IL-6 an experimental model of calcium chloride-induced AAA (151).